 | • レポートコード：D0804-15715 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、121ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、サイトメガロウイルスアッセイの世界市場を広く調査・分析し、今後の市場展望をまとめております。サイトメガロウイルスアッセイの種類別市場規模（酵素免疫測定法（ELISA）、PCR法、DNA法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Enzo Biochem、bioMerieux、Danaher、ELITech Group、BD、Merck、Eiken Chemical、Bio-Rad、Fujirebio (Miraca Holdings Inc.)、Norgen Biotek、Qiagen、DiaSorin Molecular、Abcam、BioVision (Boai NKY Medical Holdings Ltd.) ・地域別グローバル市場分析 2015年-2020年 ・サイトメガロウイルスアッセイの北米市場（アメリカ、カナダ、メキシコ） ・サイトメガロウイルスアッセイのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・サイトメガロウイルスアッセイのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・サイトメガロウイルスアッセイの南米市場（ブラジル、アルゼンチン） ・サイトメガロウイルスアッセイの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：酵素免疫測定法（ELISA）、PCR法、DNA法、その他 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Cytomegalovirus Assay market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Cytomegalovirus Assay sales will be xx in 2020 from Cytomegalovirus Assay million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Cytomegalovirus Assay market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Cytomegalovirus Assay industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Cytomegalovirus Assay and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Cytomegalovirus Assay market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cytomegalovirus Assay market has been segmented into:
Enzyme-Linked Immunosorbent Assays (ELISA)
PCR Assays
DNA Assays
Others
By Application, Cytomegalovirus Assay has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cytomegalovirus Assay market presented in the report. This section sheds light on the sales growth of different regional and country-level Cytomegalovirus Assay markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cytomegalovirus Assay market.
The report offers in-depth assessment of the growth and other aspects of the Cytomegalovirus Assay market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cytomegalovirus Assay Market Share Analysis
Cytomegalovirus Assay competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cytomegalovirus Assay sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cytomegalovirus Assay sales, revenue and market share for each player covered in this report.
The major players covered in Cytomegalovirus Assay are:
Abbott
Enzo Biochem
bioMerieux
Danaher
ELITech Group
BD
Merck
Eiken Chemical
Bio-Rad
Fujirebio (Miraca Holdings Inc.)
Norgen Biotek
Qiagen
DiaSorin Molecular
Abcam
BioVision (Boai NKY Medical Holdings Ltd.)
1 Cytomegalovirus Assay Market Overview
1.1 Product Overview and Scope of Cytomegalovirus Assay
1.2 Classification of Cytomegalovirus Assay by Type
1.2.1 Global Cytomegalovirus Assay Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cytomegalovirus Assay Revenue Market Share by Type in 2019
1.2.3 Enzyme-Linked Immunosorbent Assays (ELISA)
1.2.4 PCR Assays
1.2.5 DNA Assays
1.2.6 Others
1.3 Global Cytomegalovirus Assay Market by End Users
1.3.1 Overview: Global Cytomegalovirus Assay Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Cytomegalovirus Assay Market by Regions
1.4.1 Global Cytomegalovirus Assay Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cytomegalovirus Assay (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cytomegalovirus Assay Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cytomegalovirus Assay Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cytomegalovirus Assay Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cytomegalovirus Assay Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cytomegalovirus Assay Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Cytomegalovirus Assay Industry Impact
1.5.1 COVID-19 Potential Implications for the Cytomegalovirus Assay
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Cytomegalovirus Assay
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.2 Enzo Biochem
2.2.1 Enzo Biochem Details
2.2.2 Enzo Biochem Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Enzo Biochem SWOT Analysis
2.2.4 Enzo Biochem Product and Services
2.2.5 Enzo Biochem Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.3 bioMerieux
2.3.1 bioMerieux Details
2.3.2 bioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 bioMerieux SWOT Analysis
2.3.4 bioMerieux Product and Services
2.3.5 bioMerieux Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.4 Danaher
2.4.1 Danaher Details
2.4.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Danaher SWOT Analysis
2.4.4 Danaher Product and Services
2.4.5 Danaher Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.5 ELITech Group
2.5.1 ELITech Group Details
2.5.2 ELITech Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ELITech Group SWOT Analysis
2.5.4 ELITech Group Product and Services
2.5.5 ELITech Group Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BD SWOT Analysis
2.6.4 BD Product and Services
2.6.5 BD Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eiken Chemical
2.8.1 Eiken Chemical Details
2.8.2 Eiken Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eiken Chemical SWOT Analysis
2.8.4 Eiken Chemical Product and Services
2.8.5 Eiken Chemical Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bio-Rad
2.9.1 Bio-Rad Details
2.9.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bio-Rad SWOT Analysis
2.9.4 Bio-Rad Product and Services
2.9.5 Bio-Rad Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fujirebio (Miraca Holdings Inc.)
2.10.1 Fujirebio (Miraca Holdings Inc.) Details
2.10.2 Fujirebio (Miraca Holdings Inc.) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fujirebio (Miraca Holdings Inc.) SWOT Analysis
2.10.4 Fujirebio (Miraca Holdings Inc.) Product and Services
2.10.5 Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.11 Norgen Biotek
2.11.1 Norgen Biotek Details
2.11.2 Norgen Biotek Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Norgen Biotek SWOT Analysis
2.11.4 Norgen Biotek Product and Services
2.11.5 Norgen Biotek Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.12 Qiagen
2.12.1 Qiagen Details
2.12.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Qiagen SWOT Analysis
2.12.4 Qiagen Product and Services
2.12.5 Qiagen Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.13 DiaSorin Molecular
2.13.1 DiaSorin Molecular Details
2.13.2 DiaSorin Molecular Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 DiaSorin Molecular SWOT Analysis
2.13.4 DiaSorin Molecular Product and Services
2.13.5 DiaSorin Molecular Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.14 Abcam
2.14.1 Abcam Details
2.14.2 Abcam Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Abcam SWOT Analysis
2.14.4 Abcam Product and Services
2.14.5 Abcam Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
2.15 BioVision (Boai NKY Medical Holdings Ltd.)
2.15.1 BioVision (Boai NKY Medical Holdings Ltd.) Details
2.15.2 BioVision (Boai NKY Medical Holdings Ltd.) Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 BioVision (Boai NKY Medical Holdings Ltd.) SWOT Analysis
2.15.4 BioVision (Boai NKY Medical Holdings Ltd.) Product and Services
2.15.5 BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cytomegalovirus Assay Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cytomegalovirus Assay Players Market Share
3.2.2 Top 10 Cytomegalovirus Assay Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cytomegalovirus Assay Revenue and Market Share by Regions
4.2 North America Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
4.3 Europe Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
4.5 South America Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
5 North America Cytomegalovirus Assay Revenue by Countries
5.1 North America Cytomegalovirus Assay Revenue by Countries (2015-2020)
5.2 USA Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
5.3 Canada Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
5.4 Mexico Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
6 Europe Cytomegalovirus Assay Revenue by Countries
6.1 Europe Cytomegalovirus Assay Revenue by Countries (2015-2020)
6.2 Germany Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
6.3 UK Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
6.4 France Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
6.5 Russia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
6.6 Italy Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cytomegalovirus Assay Revenue by Countries
7.1 Asia-Pacific Cytomegalovirus Assay Revenue by Countries (2015-2020)
7.2 China Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
7.3 Japan Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
7.4 Korea Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
7.5 India Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
8 South America Cytomegalovirus Assay Revenue by Countries
8.1 South America Cytomegalovirus Assay Revenue by Countries (2015-2020)
8.2 Brazil Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
8.3 Argentina Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cytomegalovirus Assay by Countries
9.1 Middle East & Africa Cytomegalovirus Assay Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
9.3 UAE Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
9.4 Egypt Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
9.5 South Africa Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cytomegalovirus Assay Revenue and Market Share by Type (2015-2020)
10.2 Global Cytomegalovirus Assay Market Forecast by Type (2019-2024)
10.3 Enzyme-Linked Immunosorbent Assays (ELISA) Revenue Growth Rate (2015-2025)
10.4 PCR Assays Revenue Growth Rate (2015-2025)
10.5 DNA Assays Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Cytomegalovirus Assay Market Segment by End Users
11.1 Global Cytomegalovirus Assay Revenue Market Share by End Users (2015-2020)
11.2 Cytomegalovirus Assay Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Cytomegalovirus Assay Market Size Forecast (2021-2025)
12.1 Global Cytomegalovirus Assay Market Size Forecast (2021-2025)
12.2 Global Cytomegalovirus Assay Market Forecast by Regions (2021-2025)
12.3 North America Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
12.4 Europe Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
12.6 South America Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cytomegalovirus Assay Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cytomegalovirus Assay by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cytomegalovirus Assay Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cytomegalovirus Assay Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cytomegalovirus Assay Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Corporate Information, Location and Competitors
Table 7. Abbott Cytomegalovirus Assay Major Business
Table 8. Abbott Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 9. Abbott SWOT Analysis
Table 10. Abbott Cytomegalovirus Assay Product and Solutions
Table 11. Abbott Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Enzo Biochem Corporate Information, Location and Competitors
Table 13. Enzo Biochem Cytomegalovirus Assay Major Business
Table 14. Enzo Biochem Cytomegalovirus Assay Total Revenue (USD Million) (2018-2019)
Table 15. Enzo Biochem SWOT Analysis
Table 16. Enzo Biochem Cytomegalovirus Assay Product and Solutions
Table 17. Enzo Biochem Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. bioMerieux Corporate Information, Location and Competitors
Table 19. bioMerieux Cytomegalovirus Assay Major Business
Table 20. bioMerieux Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 21. bioMerieux SWOT Analysis
Table 22. bioMerieux Cytomegalovirus Assay Product and Solutions
Table 23. bioMerieux Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Danaher Corporate Information, Location and Competitors
Table 25. Danaher Cytomegalovirus Assay Major Business
Table 26. Danaher Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 27. Danaher SWOT Analysis
Table 28. Danaher Cytomegalovirus Assay Product and Solutions
Table 29. Danaher Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. ELITech Group Corporate Information, Location and Competitors
Table 31. ELITech Group Cytomegalovirus Assay Major Business
Table 32. ELITech Group Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 33. ELITech Group SWOT Analysis
Table 34. ELITech Group Cytomegalovirus Assay Product and Solutions
Table 35. ELITech Group Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. BD Corporate Information, Location and Competitors
Table 37. BD Cytomegalovirus Assay Major Business
Table 38. BD Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 39. BD SWOT Analysis
Table 40. BD Cytomegalovirus Assay Product and Solutions
Table 41. BD Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Merck Corporate Information, Location and Competitors
Table 43. Merck Cytomegalovirus Assay Major Business
Table 44. Merck Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 45. Merck SWOT Analysis
Table 46. Merck Cytomegalovirus Assay Product and Solutions
Table 47. Merck Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Eiken Chemical Corporate Information, Location and Competitors
Table 49. Eiken Chemical Cytomegalovirus Assay Major Business
Table 50. Eiken Chemical Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 51. Eiken Chemical SWOT Analysis
Table 52. Eiken Chemical Cytomegalovirus Assay Product and Solutions
Table 53. Eiken Chemical Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bio-Rad Corporate Information, Location and Competitors
Table 55. Bio-Rad Cytomegalovirus Assay Major Business
Table 56. Bio-Rad Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 57. Bio-Rad SWOT Analysis
Table 58. Bio-Rad Cytomegalovirus Assay Product and Solutions
Table 59. Bio-Rad Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Fujirebio (Miraca Holdings Inc.) Corporate Information, Location and Competitors
Table 61. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Major Business
Table 62. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 63. Fujirebio (Miraca Holdings Inc.) SWOT Analysis
Table 64. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Product and Solutions
Table 65. Fujirebio (Miraca Holdings Inc.) Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Norgen Biotek Corporate Information, Location and Competitors
Table 67. Norgen Biotek Cytomegalovirus Assay Major Business
Table 68. Norgen Biotek Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 69. Norgen Biotek SWOT Analysis
Table 70. Norgen Biotek Cytomegalovirus Assay Product and Solutions
Table 71. Norgen Biotek Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Qiagen Corporate Information, Location and Competitors
Table 73. Qiagen Cytomegalovirus Assay Major Business
Table 74. Qiagen Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 75. Qiagen SWOT Analysis
Table 76. Qiagen Cytomegalovirus Assay Product and Solutions
Table 77. Qiagen Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. DiaSorin Molecular Corporate Information, Location and Competitors
Table 79. DiaSorin Molecular Cytomegalovirus Assay Major Business
Table 80. DiaSorin Molecular Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 81. DiaSorin Molecular SWOT Analysis
Table 82. DiaSorin Molecular Cytomegalovirus Assay Product and Solutions
Table 83. DiaSorin Molecular Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Abcam Corporate Information, Location and Competitors
Table 85. Abcam Cytomegalovirus Assay Major Business
Table 86. Abcam Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 87. Abcam SWOT Analysis
Table 88. Abcam Cytomegalovirus Assay Product and Solutions
Table 89. Abcam Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. BioVision (Boai NKY Medical Holdings Ltd.) Corporate Information, Location and Competitors
Table 91. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Major Business
Table 92. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Total Revenue (USD Million) (2017-2018)
Table 93. BioVision (Boai NKY Medical Holdings Ltd.) SWOT Analysis
Table 94. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Product and Solutions
Table 95. BioVision (Boai NKY Medical Holdings Ltd.) Cytomegalovirus Assay Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Cytomegalovirus Assay Revenue (Million USD) by Players (2015-2020)
Table 97. Global Cytomegalovirus Assay Revenue Share by Players (2015-2020)
Table 98. Global Cytomegalovirus Assay Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Cytomegalovirus Assay Revenue Market Share by Regions (2015-2020)
Table 100. North America Cytomegalovirus Assay Revenue by Countries (2015-2020)
Table 101. North America Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Table 102. Europe Cytomegalovirus Assay Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Cytomegalovirus Assay Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Cytomegalovirus Assay Revenue by Countries (2015-2020)
Table 105. South America Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Cytomegalovirus Assay Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Table 108. Global Cytomegalovirus Assay Revenue (Million USD) by Type (2015-2020)
Table 109. Global Cytomegalovirus Assay Revenue Share by Type (2015-2020)
Table 110. Global Cytomegalovirus Assay Revenue Forecast by Type (2021-2025)
Table 111. Global Cytomegalovirus Assay Revenue by Application (2015-2020)
Table 112. Global Cytomegalovirus Assay Revenue Share by Application (2015-2020)
Table 113. Global Cytomegalovirus Assay Revenue Forecast by Application (2021-2025)
Table 114. Global Cytomegalovirus Assay Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cytomegalovirus Assay Picture
Figure 2. Global Cytomegalovirus Assay Revenue Market Share by Type in 2019
Figure 3. Enzyme-Linked Immunosorbent Assays (ELISA) Picture
Figure 4. PCR Assays Picture
Figure 5. DNA Assays Picture
Figure 6. Others Picture
Figure 7. Cytomegalovirus Assay Revenue Market Share by End Users in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Ambulatory Surgical Centers Picture
Figure 11. Others Picture
Figure 12. Global Cytomegalovirus Assay Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Cytomegalovirus Assay Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Cytomegalovirus Assay Revenue Market Share in 2019
Figure 21. Global Top 10 Players Cytomegalovirus Assay Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Cytomegalovirus Assay Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Cytomegalovirus Assay Revenue Market Share by Regions (2015-2020)
Figure 25. Global Cytomegalovirus Assay Revenue Market Share by Regions in 2018
Figure 26. North America Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 27. Europe Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 29. South America Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 31. North America Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Figure 32. North America Cytomegalovirus Assay Revenue Market Share by Countries in 2019
Figure 33. USA Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 34. Canada Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 36. Europe Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Cytomegalovirus Assay Revenue Market Share by Countries in 2019
Figure 38. Germany Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 39. UK Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 40. France Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 41. Russia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 42. Italy Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Cytomegalovirus Assay Revenue Market Share by Countries in 2019
Figure 45. China Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 46. Japan Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 47. Korea Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 48. India Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 50. South America Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Figure 51. South America Cytomegalovirus Assay Revenue Market Share by Countries in 2019
Figure 52. Brazil Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Cytomegalovirus Assay Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Cytomegalovirus Assay Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 57. UAE Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Cytomegalovirus Assay Revenue and Growth Rate (2015-2020)
Figure 60. Global Cytomegalovirus Assay Revenue Share by Type (2015-2020)
Figure 61. Global Cytomegalovirus Assay Revenue Share by Type in 2019
Figure 62. Global Cytomegalovirus Assay Market Share Forecast by Type (2021-2025)
Figure 63. Global Enzyme-Linked Immunosorbent Assays (ELISA) Revenue Growth Rate (2015-2020)
Figure 64. Global PCR Assays Revenue Growth Rate (2015-2020)
Figure 65. Global DNA Assays Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Cytomegalovirus Assay Revenue Share by Application (2015-2020)
Figure 68. Global Cytomegalovirus Assay Revenue Share by Application in 2019
Figure 69. Global Cytomegalovirus Assay Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Cytomegalovirus Assay Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Cytomegalovirus Assay Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Cytomegalovirus Assay Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
Figure 78. Europe Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
Figure 80. South America Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Cytomegalovirus Assay Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
次世代分子アッセイの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Next Generation Molecular Assay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Next Generati…- 抗凝固治療薬モニタリングアッセイキットの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anticoagulant Therapeutic Drug Monitoring Assay Kit market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…
- 糖尿病アッセイの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Diabetic Assay market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetic Assay market report p…
- エンドトキシンアッセイキットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Endotoxin Assay Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- B-ヒドロキシブチレート（ケトン体）アッセイキットの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The B-Hydroxybutyrate (Ketone Body) Assay Kit market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…